This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.


                                                                                

78R5404 KKA-F

By:  Ellis                                                        S.B. No. 797


A BILL TO BE ENTITLED
AN ACT
relating to a prescription drug purchasing program and an associated assistance program. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Chapter 531, Government Code, is amended by adding Subchapter K to read as follows:
SUBCHAPTER K. FAIR MARKET PRESCRIPTION DRUG PRICING AND PRESCRIPTION DRUG ASSISTANCE PROGRAM
Sec. 531.401. PURPOSE. The purpose of this subchapter is to: (1) reduce the cost of prescription drugs provided by the state through the Medicaid program and other state-funded programs; (2) make prescription drugs more affordable for uninsured or underinsured state residents; and (3) prevent uninsured and underinsured state residents from requiring assistance under the Medicaid program as a result of the inability of those residents to otherwise obtain medically necessary care due to excessive prescription drug prices. Sec. 531.402. DEFINITIONS. In this subchapter: (1) "Labeler" means a person that: (A) has a labeler code from the Food and Drug Administration under 21 C.F.R. Section 207.20; and (B) receives prescription drugs from a manufacturer or wholesaler and repackages those drugs for later retail sale. (2) "Manufacturer" means a manufacturer of prescription drugs as defined by 42 U.S.C. Section 1396r-8(k)(5), including a subsidiary or affiliate of a manufacturer. (3) "Wholesaler" means a person licensed under Subchapter I, Chapter 431, Health and Safety Code. Sec. 531.403. NEGOTIATED PRESCRIPTION DRUG REBATES AND DISCOUNT PRICES. (a) The commission shall negotiate with manufacturers and labelers to obtain rebates or discount prices for prescription drugs sold in this state. In negotiating terms for rebates or discount prices, the commission shall consider: (1) rebates calculated under the Medicaid rebate program in accordance with 42 U.S.C. Section 1396r-8; (2) prices at which prescription drugs are provided to eligible entities under 42 U.S.C. Section 256b; and (3) any other available information on prescription drug prices, rebates, or discounts. (b) A manufacturer or labeler may voluntarily negotiate with the commission and enter into an agreement to provide: (1) supplemental rebates for prescription drugs provided under the Medicaid program in excess of the rebates required by 42 U.S.C. Section 1396r-8; (2) rebates for prescription drugs provided under the Tex-Rx card program established under Section 531.405; or (3) rebates or discount prices for prescription drugs provided under any other state program that pays for or acquires prescription drugs. Sec. 531.404. PRIOR AUTHORIZATION REQUIREMENTS. (a) If the commission and a manufacturer or labeler fail to reach an agreement on supplemental Medicaid rebates and rebates for the Tex-Rx card program established under Section 531.405 resulting in the availability of prescription drugs at prices available to eligible entities under 42 U.S.C. Section 256b, the commission shall: (1) place the products of the manufacturer or labeler on the state's list of products requiring prior authorization under the Medicaid program or any other state-funded program; and (2) post the name of the manufacturer or labeler on the commission's Internet site. (b) Placement of products on a prior authorization list in accordance with this section must be conducted in a manner that complies with 42 U.S.C. Section 1396r-8(d)(5). (c) The commission shall distribute to physicians, pharmacists, and other health professionals in this state information regarding the relative costs of prescription drugs provided by manufacturers and labelers who have entered into agreements with the commission under this subchapter and prescription drugs provided by manufacturers and labelers who have not entered into agreements with the commission under this subchapter. Sec. 531.405. TEX-RX CARD PROGRAM: GENERAL PROVISIONS. (a) Using rebates obtained through negotiations required by Section 531.403, the commission shall establish a Tex-Rx card program as a state pharmaceutical assistance program under 42 U.S.C. Section 1396r-8(c)(1)(C)(i)(III). (b) The program does not pay for any prescription drug for any program participant, but promotes the use of certain effective prescription drugs by enabling participants to purchase those drugs at a discounted price. (c) The program shall provide discounted prices to program participants for each prescription drug subject to a rebate through an agreement under Section 531.403(b)(2). (d) The commission shall contract with wholesalers or retail pharmacies that voluntarily elect to participate in the program as necessary to deliver discounted prices to program participants. (e) Subject to Subsection (f), a person is eligible to participate in the program if the person is a resident of this state and: (1) is eligible for assistance under the Medicare program; or (2) has a net family income that is below 300 percent of the federal poverty level. (f) A person may not participate in the program if the person is: (1) eligible for assistance under the Medicaid program; or (2) covered by an insurance policy or health benefit plan that provides benefits for prescription drugs at a level at least equal to the benefits provided by the program, as determined in accordance with commission rules. (g) The commission shall engage in outreach activities to publicize the availability of discounted prescription drug prices under the program and shall establish simple procedures for enrolling program participants. Sec. 531.406. PARTICIPATING RETAIL PHARMACIES AND WHOLESALERS. (a) A retail pharmacy that voluntarily participates in the Tex-Rx card program established under Section 531.405 shall provide a prescription drug available through the program to a program participant at a price not to exceed the sum of: (1) the pharmacy's acquisition cost under the program; and (2) a dispensing fee in an amount equal to 105 percent of the dispensing fee paid for providing the drug under the Medicaid program. (b) The commission by rule shall require a participating retail pharmacy to: (1) maintain a separate inventory of prescription drugs obtained by the pharmacy under the program or segregate those drugs from the pharmacy's other prescription drug stock; (2) maintain separate records of acquisition and disposition of prescription drugs obtained by the pharmacy under the program, and ensure that all computer records regarding those drugs are readily available to the commission; and (3) return excess prescription drugs obtained by the pharmacy under the program to the appropriate wholesaler from whom the drugs were obtained. (c) A participating retail pharmacy or wholesaler may not resell or otherwise transfer a prescription drug obtained under the program to: (1) a retail pharmacy that is not participating in the program; or (2) a consumer who is not a program participant. (d) If the commission, after notice and opportunity for a hearing, determines that a participating retail pharmacy or wholesaler has acted in violation of Subsection (c), the pharmacy or wholesaler is liable to the manufacturer of the prescription drug in an amount equal to the difference between: (1) the retail price of the drug at the time of the wrongful resale or transfer; and (2) the price at which the drug was obtained by the pharmacy or wholesaler under the program. Sec. 531.407. REBATE DISPUTES OR DISCREPANCIES. (a) A dispute or discrepancy in the amount of a rebate negotiated under Section 531.403 must be resolved using the process established in this section. (b) The commission may hire an independent auditor acceptable to all affected parties to perform an audit at the commission's expense if there is a dispute or discrepancy in favor of a manufacturer or labeler relating to the amount rebated for a prescription drug provided by the manufacturer or labeler. If the audit does not resolve the dispute or discrepancy, the manufacturer or labeler shall: (1) provide justification for the dispute or discrepancy that is satisfactory to the commission; or (2) pay the additional amount due. (c) A manufacturer or labeler may hire an independent auditor acceptable to all affected parties to perform an audit at the expense of the manufacturer or labeler if there is a dispute or discrepancy in favor of this state relating to the amount rebated for a prescription drug provided by the manufacturer or labeler. If the audit does not resolve the dispute or discrepancy, the commission shall: (1) provide justification for the dispute or discrepancy that is satisfactory to the manufacturer or labeler; or (2) refund to the manufacturer or labeler the amount due. (d) Any party not satisfied with the resolution of a dispute or discrepancy in accordance with Subsection (b) or (c) may request in writing a hearing before the State Office of Administrative Hearings. The party must include supporting documentation with the request for a hearing. Sec. 531.408. RULEMAKING. The commission shall adopt rules as necessary to administer this subchapter. Sec. 531.409. ANNUAL REPORT. Not later than January 1 of each odd-numbered year, the commission shall report to the legislature on the commission's activities under this subchapter. The report must include: (1) the number of persons enrolled in the Tex-Rx card program established under Section 531.405 and information regarding the financial condition of that program; and (2) the amount of savings achieved for the state as a result of rebates and discount prices negotiated in accordance with Section 531.403. SECTION 2. If before implementing any provision of this Act a state agency determines that a waiver or authorization from a federal agency is necessary for implementation of that provision, the agency affected by the provision shall request the waiver or authorization and may delay implementing that provision until the waiver or authorization is granted. SECTION 3. (a) The Health and Human Services Commission shall implement Sections 531.403 and 531.404, Government Code, as added by this Act, not later than January 1, 2004. (b) The Health and Human Services Commission shall implement the Tex-Rx card program required by Sections 531.405 and 531.406 not later than January 1, 2005, if the commission determines that adequate resources are available to support the program as a result of the negotiations required by Section 531.403, Government Code, as added by this Act. If adequate resources are not available to support implementation of the program, the commission may delay implementation of the program until adequate resources are available. SECTION 4. This Act takes effect immediately if it receives a vote of two-thirds of all the members elected to each house, as provided by Section 39, Article III, Texas Constitution. If this Act does not receive the vote necessary for immediate effect, this Act takes effect September 1, 2003.